Edition:
United States

Asahi Kasei Corp (3407.T)

3407.T on Tokyo Stock Exchange

1,682JPY
25 Sep 2018
Change (% chg)

¥14 (+0.84%)
Prev Close
¥1,668
Open
¥1,671
Day's High
¥1,684
Day's Low
¥1,648
Volume
4,546,200
Avg. Vol
3,079,298
52-wk High
¥1,714
52-wk Low
¥1,260

Latest Key Developments (Source: Significant Developments)

Asahi Kasei Corp Has Moved Production Of U.S.-Bound Resin Feedstock To Okayama Prefecture, Japan-Nikkei
Tuesday, 28 Aug 2018 03:05pm EDT 

Aug 29 (Reuters) - Nikkei::ASAHI KASEI CORP HAS MOVED PRODUCTION OF U.S.-BOUND RESIN FEEDSTOCK FROM CHINA TO WESTERN JAPAN'S OKAYAMA PREFECTURE - NIKKEI.  Full Article

Asahi Kasei's Group Operating Profit Seen Climbing 20% To Around 190 Bln Yen - Nikkei
Wednesday, 31 Jan 2018 12:45pm EST 

Jan 31 (Reuters) - Nikkei::ASAHI KASEI CORP'S GROUP OPERATING PROFIT IS SEEN CLIMBING 20 PERCENT TO AROUND 190 BILLION YEN IN THE FISCAL YEAR ENDING MARCH 31 - NIKKEI.ASAHI KASEI CORP’S SALES ARE SEEN GROWING 10%, EXCEEDING 2 TRILLION YEN IN THE FISCAL YEAR ENDING MARCH 31 - NIKKEI ‍​.  Full Article

Asahi Kasei To Invest Extra 30 Billion Yen Into Battery Separator Production - Nikkei‍​
Thursday, 30 Nov 2017 01:32pm EST 

Dec 1(Reuters) - Nikkei : :ASAHI KASEI TO INVEST EXTRA 30 BLN YEN ($268 MLN) TO BOOST PRODUCTION OF SEPARATORS FOR LITHIUM-ION BATTERIES - NIKKEI.ASAHI KASEI IS ALSO EXPANDING CAPACITY AT POLYPORE, NEW FACTORIES ARE BEING CONSIDERED FOR EASTERN EUROPE AND SOUTH KOREA - NIKKEI‍​.  Full Article

R&I affirms Asahi Kasei's rating at "AA-" and says stable outlook -R&I
Monday, 13 Nov 2017 01:24am EST 

Nov 13 (Reuters) - Asahi Kasei Corp <3407.T>:Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA-" -R&I.Says rating outlook stable -R&I.  Full Article

Bone Therapeutics and Asahi Kasei sign exclusive license agreement for Preob in Japan
Friday, 22 Sep 2017 01:00am EDT 

Sept 22 (Reuters) - BONE THERAPEUTICS ::REG-BONE THERAPEUTICS SA AND ASAHI KASEI SIGN EXCLUSIVE LICENSE AGREEMENT FOR PREOB® IN JAPAN.REG-BONE THERAPEUTICS SA AND ASAHI KASEI SIGN EXCLUSIVE LICENSE AGREEMENT FOR PREOB® IN JAPAN.‍ASAHI KASEI WILL OBTAIN EXCLUSIVE RIGHTS TO DEVELOP, REGISTER AND COMMERCIALISE PREOB FOR TREATMENT OF OSTEONECROSIS OF HIP IN JAPAN.​.TO RECEIVE UPFRONT PAYMENT OF EUR 1.7 MILLION FROM ASAHI KASEI.ALSO GRANTED ASAHI KASEI OPTION TO NEGOTIATE AN EXCLUSIVE LICENSE FOR DEVELOPMENT AND COMMERCIALIZATION OF PREOB IN KOREA, CHINA AND TAIWAN.​.TO RECEIVE UP TO EUR 7.5 MILLION FROM DEVELOPMENT AND COMMERCIAL MILESTONE PAYMENTS.TO RECEIVE TIERED ROYALTIES BASED ON ANNUAL NET SALES OF PREOB IN JAPAN.  Full Article

Asahi Kasei says verdict of jury trial for damages related to unit
Thursday, 3 Aug 2017 10:31pm EDT 

Aug 4 (Reuters) - Asahi Kasei Corp <3407.T>:* Says a verdict was issued today in a jury trial of the United States District Court for the District of Massachusetts in litigation instigated by Koninklijke Philips Electronics N.V. and Philips Electronics North America Corporation against unit ZOLL Medical Corporation on June 18, 2010.* According to verdict, Philips was requested to pay $3.3 million to ZOLL and ZOLL was requested to pay $10.4 million to Philips .  Full Article

Asahi Kasei's operating profit likely rose 30 pct for April-June quarter - Nikkei
Thursday, 20 Jul 2017 01:09pm EDT 

July 20 (Reuters) - Nikkei::Asahi Kasei Corp's operating profit likely rose 30 percent to around 38 billion yen for the April-June quarter - Nikkei.Asahi Kasei Corp's sales for the April-June quarter likely grew just under 10 percent to more than 450 billion yen - Nikkei.Asahi Kasei may upgrade forecast for April-September operating profit - Nikkei.  Full Article

Asahi Kasei likely will post smaller decline in operating profit than forecast for the year ended in March- Nikkei
Tuesday, 25 Apr 2017 01:16pm EDT 

April 25 (Reuters) - Nikkei: :Asahi Kasei likely will post smaller decline in operating profit than forecast for the year ended in March, with 3% drop - Nikkei.Asahi Kasei Corp's group sales for year ended March 2017 likely came near its guidance of 1.87 trillion yen, a 4% decline - Nikkei.  Full Article

Asahi Kasei to boost battery component output by 30%- Nikkei
Wednesday, 29 Mar 2017 06:34pm EDT 

Nikkei:Asahi Kasei to increase output of separators used in lithium ion batteries by 30 pct; will spend from 11 billion yen to 19 billion yen by 2019 - Nikkei.  Full Article

ZOLL Hospital Wearable Defibrillator receives premarket approval from FDA
Thursday, 9 Mar 2017 10:44am EST 

ZOLL Medical Corporation :ZOLL Hospital Wearable Defibrillator receives premarket approval from the FDA.  Full Article